Fierce JPM Week 2025 - Virtual: Full Schedule

arrow_back View All Dates

9:30am EST

Opening Fireside Chat: Noubar Afeyan, Founder and CEO, Flagship Pioneering; Co-Founder and Chairman, Moderna

Wednesday January 22, 2025 9:30am - 9:50am EST

Virtual

Moderators

Gabrielle Masson

Associate Editor, Fierce Biotech

Gabrielle Masson is an associate editor for Fierce Biotech. Prior to Fierce, she worked at Becker's Hospital Review, where she reported on public health and the pandemic. Gabrielle graduated from the University of Wisconsin-Madison after studying creative writing and criminal justice... Read More →

Speakers

Noubar Afeyan

Founder and CEO, Flagship Pioneering; Co-Founder and Board Chairman, Moderna

Noubar Afeyan is founder and CEO of Flagship Pioneering. He is also co-founder and Board Chairman of Moderna.Founded in 2000, Flagship is an enterprise where entrepreneurially-minded scientists invent seemingly unreasonable solutions to challenges facing human health and sustainability. They begin by asking “What if?” and iterate toward the unexpected answers resulting in the creation... Read More →

Wednesday January 22, 2025 9:30am - 9:50am EST
Virtual

Keynote

9:50am EST

How can the Combination of Agentic and Human Intelligence Transform Drug Discovery, Development, and Diagnostics?

Wednesday January 22, 2025 9:50am - 10:20am EST

Virtual

This panel will explore how agentic AI and human intelligence will transform drug development, from early-stage discovery and target identification to optimizing clinical trials and advancing personalized treatments. Key topics include AI’s role in accelerating research, improving trial design, and enhancing patient recruitment. The discussion will also address the challenges of understanding complex biology, ensuring data quality, and fostering cross-industry collaboration. By harnessing collective intelligence, the panel will highlight how these technologies can drive innovation, efficiency, and personalization across the drug development pipeline by harnessing collective intelligence.

Moderators

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences

Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →

Speakers

Thomas Clozel, MD

Co-Founder & CEO, Owkin

Thomas is the CEO and Co-Founder of Owkin, leading medical research and business intelligence. He is a former Assistant Professor of Clinical Onco-Hematology at Hopital Henri Mondor in Paris and a former member of Ari Melnick’s lab at Weill Cornell Medical College, where he co-led... Read More →

Emmanuel Frenehard

Executive Vice President, Chief Digital Officer, Sanofi

Emmanuel Frenehard oversees Sanofi’s digital, data and technology strategy to help transform the practice of medicine, empower healthcare professionals, and better serve patients.Emmanuel joined Sanofi four years ago. Prior to being appointed Chief Digital Officer, he held the positions... Read More →

Jorge S. Reis-Filho, MD PhD FRCPath

VP Cancer Biomarker Development, Early Oncology,, AstraZeneca

Jorge S. Reis-Filho is the VP, Cancer Biomarker Development at AstraZeneca, whose mission is to develop mechanistically-informed but clinically-deployable biomarkers to deliver the right therapeutic agents to cancer patients at the right time during their therapeutic journey. Dr... Read More →

Greg Meyers

Executive Vice President, Chief Digital & Technology Officer, BMS

Greg Meyers, executive vice president and chief digital and technology officer, leads the company’s efforts to coalesce digital technology alongside the company's transformational science to get more medicines, to more patients, faster and more impactfully.In his role, Greg leads... Read More →

Wednesday January 22, 2025 9:50am - 10:20am EST
Virtual

Keynote